Healthcare IT Is a $981B Market by 2032: Where Software Companies Should Focus

The healthcare IT market is projected to reach $981 billion by 2032, growing at a CAGR of approximately 15.8% from its estimated $330 billion base in 2024. For software development companies evaluating sector opportunities, this is the single largest technology market in the global economy — growing faster than enterprise SaaS, faster than fintech, and faster than cybersecurity.

But aggregate market projections mask the strategic question that matters: where within this enormous market should software development companies actually focus?

Not all segments are equally accessible to custom software development firms. Some are dominated by entrenched incumbents with multi-billion-dollar platforms. Others are emerging rapidly with fragmented competition and acute demand for specialized development capabilities. The difference between picking the right segment and the wrong one can mean the difference between a thriving practice and an expensive pivot.

SectorPunk has analyzed the five fastest-growing segments to identify where specialized software development companies can compete most effectively.

The Five Fastest-Growing Healthcare IT Segments

1. Healthcare AI — $187.6 Billion by 2030

The fastest-growing segment by CAGR (38.4%), healthcare AI encompasses clinical decision support, diagnostic imaging AI, drug discovery, operational optimization, and NLP for clinical documentation.

Incumbent dominance at the infrastructure layer:

• Microsoft (Nuance), Google Health, and NVIDIA provide foundational models, cloud compute, and development frameworks

• At the application layer, the market remains highly fragmented — hundreds of AI startups pursuing specific clinical niches

The real opportunity for software companies:

• Not building yet another AI model — it's building the integration, deployment, and monitoring infrastructure that connects AI models to clinical workflows

• Approximately half of US hospitals report they cannot scale AI beyond pilots — this is fundamentally an engineering and integration problem, not an algorithm problem

• EHR integration expertise, MLOps pipeline development, and clinical workflow embedding are the highest-value capabilities

2. Telemedicine — $431.8 Billion by 2030

The largest segment by projected market size, driven by permanent behavioral changes from COVID-19. Platform-level competition (Teladoc, Amwell, MDLive, Epic native) is intense — competing there is not viable for custom development firms.

Where custom development wins:

• Telepsychiatry — platforms with AI-powered sentiment analysis and therapy adherence tracking

• Tele-dermatology — image-based diagnostic support with dermoscopy integration

• Remote rehabilitation — motion capture, exercise compliance tracking, and progress measurement

• Chronic disease management — platforms integrating continuous monitoring data with virtual visit workflows

These specialized applications require deep clinical domain knowledge that platform vendors cannot replicate across every specialty.

3. Clinical Decision Support — $7.8 Billion by 2030

Smaller in absolute terms but technically demanding — and where specialized software companies have disproportionate advantage.

The migration underway:

• Legacy CDS systems are rule-based, generating high volumes of clinically irrelevant alerts

• AI-powered CDS uses machine learning to deliver contextually relevant recommendations while suppressing alert fatigue

• EHR vendors provide basic infrastructure (Epic's BestPractice Advisories, Oracle Health's Discern Rules), but the clinical intelligence layer is increasingly outsourced

Key technical requirements:

• CDS Hooks-based services for real-time integration with EHR workflows

• SMART on FHIR application development for portable clinical applications

• Collaboration with clinical informaticists who understand both evidence base and clinical workflow

4. Revenue Cycle Management AI — $20.8 Billion by 2030

The financial backbone of healthcare operations — US hospitals collectively lose an estimated $262 billion annually to billing and coding inefficiencies.

The AI arms race:

• Payers increasingly use AI to deny claims, creating arms race on the provider side

• Major platforms (Waystar, R1 RCM, Optum) have built AI capabilities, but billing complexity varies by payer, state, and hospital system

Custom development opportunity:

• AI models trained on institution-specific billing data and payer-specific denial patterns

• Specialty-specific coding complexity that generic platforms cannot optimize

• Prior authorization automation tailored to individual payer requirements

5. Remote Patient Monitoring — $312 Billion by 2032

Driven by wearable sensor convergence, cellular connectivity, and payer reimbursement for remote monitoring.

Hardware is commoditized — the software layer differentiates:

• Algorithms filtering noise from signal across heterogeneous device types

• Predicting adverse events before they occur using continuous physiological data

• Prioritizing clinical team attention across patient panels of hundreds or thousands

• EHR integration for clinical context and FDA SaMD compliance for AI components

Segment Comparison for Software Companies

Segment	Market Size (Projected)	CAGR	Key Incumbents	Best-Fit Development Expertise
Healthcare AI	$187.6B by 2030	38.4%	Microsoft/Nuance, Google Health, NVIDIA	EHR integration, MLOps, clinical workflow
Telemedicine	$431.8B by 2030	25.2%	Teladoc, Amwell, Epic	Specialty-specific platforms, remote diagnostics
Clinical Decision Support	$7.8B by 2030	14.7%	Epic, Oracle Health, Wolters Kluwer	CDS Hooks, SMART on FHIR, clinical informatics
Revenue Cycle Management AI	$20.8B by 2030	19.1%	Waystar, R1 RCM, Optum	Billing AI, NLP for coding, denial prediction
Remote Patient Monitoring	$312B by 2032	26.7%	Philips, Medtronic, BioTelemetry	IoT data pipelines, signal processing, FDA SaMD

Where Custom Software Companies Can Compete vs. Incumbents

The competitive dynamics share a common pattern:

• Incumbents dominate the horizontal platform layer — EHR vendors, cloud providers, large RCM platforms competing on scale, network effects, and existing relationships

• Custom software companies should NOT compete at this layer

The accessible market sits at the intersection of three characteristics:

• Clinical domain specificity — problems requiring deep understanding of a particular medical specialty's workflow

• Integration complexity — solutions that must work within existing EHR and clinical infrastructure

• Regulatory sophistication — products that must comply with FDA, HIPAA, and increasingly the EU AI Act

Problems exhibiting all three characteristics are structurally difficult for incumbent platforms to solve at sufficient depth. Reasonable estimates suggest this intersection represents 15–25% of the overall healthcare IT market — a $150–250 billion opportunity.

Adjacent Opportunities

Interoperability Middleware

Integration engines, data transformation layers, and API management platforms connecting disparate clinical systems. The 21st Century Cures Act and TEFCA (Trusted Exchange Framework and Common Agreement) are creating new interoperability requirements driving demand through at least 2028.

Compliance Tooling

The expanding regulatory landscape — HIPAA, FDA SaMD, EU AI Act, state-level AI regulations — creates demand for:

• Compliance management software and audit trail systems

• Regulatory documentation generators

• Bias monitoring platforms for healthcare AI

• These tools serve healthcare software companies themselves and can be productized as platforms

Data Analytics Infrastructure

Clinical data warehouses, real-world evidence platforms, and population health analytics dashboards require specialized healthcare data engineering that general-purpose analytics platforms cannot provide out of the box.

Strategic Implications

The healthcare IT market's growth to $981 billion by 2032 is not a rising tide that lifts all boats equally:

• Generalist companies entering healthcare without domain investment will compete on price for commodity integration work

• Specialized companies investing in clinical expertise, regulatory fluency, and deep EHR integration will find premium pricing, long-term contracts, and barriers to competitive displacement

The best healthcare software development companies are already making these bets. In a $981 billion market, the strategic question is not whether to participate — it is where to focus and how deeply to invest.

Published February 27, 2026 · SectorPunk Research